The Centers for Disease Control and Prevention recommends chlamydia screening at intake for all females in juvenile detention facilities. Identifying factors predictive of chlamydia could enable targeted screening, reducing costs while still identifying most infections. This study used demographic, arrest, and health data to identify factors associated with chlamydia among females aged 12 to 18 years entering a juvenile detention facility in San Diego during January 2009 to June 2010. The study created different screening criteria based on combinations of factors associated with infection and calculated sensitivity and proportion screened for each criterion. Overall chlamydia prevalence was 10.3% and was 4.2% among females reporting no sexual risk factors. No acceptable targeted screening approach was identified. High prevalence, even among females without risk factors, supports universal screening at intake.
Centers for Disease Control and Prevention. (2011). Sexually transmitted disease surveillance, 2010. Atlanta, GA: Department of Health and Human Services. Retrieved from http://www.cdc.gov/std/stats10/surv2010.pdf
2.
DattaS. D., TorroneE., Kruszon-MoranD., BermanS., JohnsonR., SatterwhiteC. L.…WeinstockH. (2012). Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sexually Transmitted Diseases, 39, 92–96. doi:10.1097/OLQ.0b013e31823e2ff7
3.
FarleyT. A., CohenD. A., ElkinsW. (2003). Asymptomatic sexually transmitted diseases: The case for screening. Preventive Medicine, 36, 502–509.
JoesoefM. R., WeinstockH. S., KentC. K., ChowJ. M., BoudovM. R., ParvezF. M., … Corrections STD Prevalence Monitoring Group. (2009). Sex and age correlates of chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: Implications for screening policy. Sexually Transmitted Diseases, 36, S67–S71. doi:10.1097/OLQ.0b013e31815d6de8
6.
KleinbaumD. (2002). Logistic regression: A self-learning text. New York, NY: Springer.
7.
KouyoumdjianF. G., LetoD., JohnS., HeneinH., BondyS. (2012). A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. International Journal of STD and AIDS, 23, 248–254. doi:10.1258/ijsa.2011.011194
8.
MarrazzoJ. M., CelumC. L., HillisS. D., FineD., DeLisleS., HandsfieldH. H. (1997). Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national chlamydia control strategy. Sexually Transmitted Diseases, 24, 131–141.
9.
MartinD. H. (2012). The US Chlamydia trachomatis control program: Successes, shortcomings and ideas for the future. Sexually Transmitted Diseases, 39, 913–916. doi:10.1097/OLQ.0b013e3182787e5e
10.
MillerJ. L., SamoffE., BolanG., & Chlamydia Screening Project (ClaSP) Group. (2009). Implementing chlamydia screening programs in juvenile correctional settings: The California experience. Sexually Transmitted Diseases, 36, S53–S57. doi:10.1097/OLQ.0b013e3181644658
11.
National Committee for Quality Assurance. (2012). The state of health care quality 2012. Washington, DC: Author.
12.
PetermanT. A., NewmanD. R., CollinsD. E., DoshiS. R., BermanS. M. (2011). Sexually transmitted diseases program performance measures: How are they performing?. Sexually Transmitted Diseases, 38, 610–616. doi:10.1097/OLQ.0b013e31820a8d9b
13.
SatterwhiteC. L., TianL. H., BraxtonJ., WeinstockH. (2010). Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003-2007. Sexually Transmitted Diseases, 37, 63–67. doi:10.1097/OLQ.0b013e3181bc097a
14.
SpauldingA. C., MillerJ., TriggB. G., BravermanP., LincolnT., ReamsP. N.…SatterwhiteC. L. (2013). Screening for sexually transmitted diseases in short-term correctional institutions: Summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Sexually Transmitted Diseases, 40, 679–684. doi:10.1097/01.olq.0000431353.88464.ab
15.
StammW. (2007). Chlamydia trachomatis infections of the adult. In HolmesK. K., SparlingP. F., StammW. E., PiotP., WasserheitJ. N., CoreyL., CohenM. S., WattsD. H. (Eds.), Sexually transmitted diseases (4th ed., pp. 575–593). New York, NY: McGraw-Hill.
16.
TorroneE., PappJ., WeinstockH. (2014). Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years—United States, 2007-2012. Morbidity and Mortality Weekly Report, 63, 834–838.
WorkowskiK. A., BolanG. A., & Centers for Disease Control and Prevention (CDC). (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64, 1–137.
